Delivery Order SPE2DE21D0017-SPE2D625F2QZK
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 28, 2025, for COVID-19 test kits with a ceiling value of $2,400.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of May 7, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain, operating under...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 on September 9, 2025, for COVID-19 test kits under contract 4569386625. The contract utilizes fixed-price pricing with economic price adjustment and has an ultimate completion date of September 18, 2025. Performance will occur in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding source is the Defense...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on July 14, 2025, for COVID-19 test kits under contract number 4568782066. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of July 23, 2025. The award was made without set-aside designation, indicating open competition. Funding is provided through the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 18, 2025, for COVID-19 test kits to support the Defense Logistics Agency Medical Supply Chain. The contract, designated as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of September 29, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating the...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order contract valued at $6,000 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on September 16, 2025, with an ultimate completion date of September 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance of this...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $3.55 million delivery order contract to provide COVID-19 test kits. The fixed-price with economic price adjustment contract has a period of performance from August 30, 2023 to September 11, 2023, with delivery of the test kits to take place in Lockhart, Florida. Abbott Rapid DX North America LLC will fulfill the agency's requirement for COVID-19 testing as it...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $4,800.00 fixed-price delivery order with economic price adjustment on June 2, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract, which carries no set-aside designation indicating open competition, is scheduled for ultimate completion on June 10, 2025, and will be performed in Lockhart, Florida. Funding is provided by the Defense Logistics Agency's Medical Supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,328.00 fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide COVID-19 test kits. The contract has an ultimate completion date of November 22, 2024. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to federal agencies like the Department of Veterans Affairs (VA) and Department of...
- This federal contract award, valued at $1,776.00, was issued by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is a delivery order for COVID-19 test kits, with a fixed-price structure and economic price adjustment. It has an ultimate completion date of November 26, 2024. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests,...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F2QZKDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 5, 2025, for COVID-19 test kits valued at $15,000.00 with a completion date of September 16, 2025. This fixed-price contract with economic price adjustment clauses was awarded without set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain funded this award, and performance will be completed in Lockhart, Florida. The delivery order represents a continuation of Abbott's substantial role as a critical federal supplier of diagnostic testing products, particularly COVID-19 rapid antigen tests and related diagnostic equipment. Abbott Rapid DX North America LLC has established itself as a key vendor to the Defense Logistics Agency and Department of Veterans Affairs through multiple contract vehicles, including several Blanket Purchase Agreements valued in excess of $240,000.00 for point-of-care testing services. This award supports ongoing testing and diagnostic needs across federal healthcare facilities as part of the government's sustained medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 9/5/25 |